{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:01:22Z","timestamp":1771599682369,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["2025-I2M-C&T-B-050"],"award-info":[{"award-number":["2025-I2M-C&T-B-050"]}]},{"name":"Shenzhen Medical Research Fund","award":["C2301001"],"award-info":[{"award-number":["C2301001"]}]},{"name":"Cooperation Fund of CHCAMS and SZCH","award":["CFA202501001"],"award-info":[{"award-number":["CFA202501001"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473248"],"award-info":[{"award-number":["82473248"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15643-w","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T02:13:14Z","timestamp":1769479994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term outcomes and anorectal functional status of patients with anal squamous cell carcinoma treated with the modern technique of intensity-modulated radiotherapy"],"prefix":"10.1186","volume":"26","author":[{"given":"Tongzhen","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiacheng","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shulian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongwen","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningning","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yirui","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yexiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"5","key":"15643_CR1","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"H Bartelink","year":"1997","unstructured":"Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European organization for research and treatment of cancer radiotherapy and Gastrointestinal cooperative groups. J Clin Oncology: Official J Am Soc Clin Oncol. 1997;15(5):2040\u20139.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"7","key":"15643_CR2","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","volume":"102","author":"J Northover","year":"2010","unstructured":"Northover J, Glynne-Jones R, Sebag-Montefiore D, James R, Meadows H, Wan S, et al. Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR anal cancer trial (ACT I). Br J Cancer. 2010;102(7):1123\u20138.","journal-title":"Br J Cancer"},{"issue":"35","key":"15643_CR3","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","volume":"30","author":"LL Gunderson","year":"2012","unstructured":"Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson AB 3, et al. Long-term update of US GI intergroup RTOG 98\u2009\u2013\u200911 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin. J Clin Oncology: Official J Am Soc Clin Oncol. 2012;30(35):4344\u201351.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"16","key":"15643_CR4","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","volume":"299","author":"JA Ajani","year":"2008","unstructured":"Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB 3rd, Thomas CR Jr., et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA. 2008;299(16):1914\u201321.","journal-title":"JAMA"},{"issue":"9","key":"15643_CR5","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","volume":"14","author":"M Flam","year":"1996","unstructured":"Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncology: Official J Am Soc Clin Oncol. 1996;14(9):2527\u201339.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"9034","key":"15643_CR6","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","volume":"348","author":"Epidermoid anal cancer","year":"1996","unstructured":"Epidermoid anal cancer. : results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR anal cancer trial working Party. UK Co-ordinating committee on cancer research. Lancet (London England). 1996;348(9034):1049\u201354.","journal-title":"Lancet (London England)"},{"issue":"34","key":"15643_CR7","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1200\/JCO.2010.29.1351","volume":"28","author":"E Ben-Josef","year":"2010","unstructured":"Ben-Josef E, Moughan J, Ajani JA, Flam M, Gunderson L, Pollock J, et al. Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of radiation therapy oncology group trials 87\u2009\u2013\u200904 and 98\u2009\u2013\u200911. J Clin Oncology: Official J Am Soc Clin Oncol. 2010;28(34):5061\u20136.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"3","key":"15643_CR8","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/j.ijrobp.2012.09.034","volume":"85","author":"L Moureau-Zabotto","year":"2013","unstructured":"Moureau-Zabotto L, Ortholan C, Hannoun-Levi JM, Teissier E, Cowen D, Salem N, et al. Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 study). Int J Radiat Oncol Biol Phys. 2013;85(3):e135\u201342.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"15643_CR9","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","volume":"74","author":"RJ Myerson","year":"2009","unstructured":"Myerson RJ, Garofalo MC, El Naqa I, Abrams RA, Apte A, Bosch WR, et al. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys. 2009;74(3):824\u201330.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"15643_CR10","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","volume":"83","author":"M Ng","year":"2012","unstructured":"Ng M, Leong T, Chander S, Chu J, Kneebone A, Carroll S, et al. Australasian Gastrointestinal trials group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer. Int J Radiat Oncol Biol Phys. 2012;83(5):1455\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"15643_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","volume":"86","author":"LA Kachnic","year":"2013","unstructured":"Kachnic LA, Winter K, Myerson RJ, Goodyear MD, Willins J, Esthappan J, et al. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal Canal. Int J Radiat Oncol Biol Phys. 2013;86(1):27\u201333.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"15643_CR12","unstructured":"U.S. National Institutes of Health NCI. Common Terminology Criteria for Adverse Events (CTCAE) version 4.0 2010. Available from: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_50."},{"issue":"1","key":"15643_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF02050307","volume":"36","author":"JM Jorge","year":"1993","unstructured":"Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993;36(1):77\u201397.","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"15643_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/gut.44.1.77","volume":"44","author":"CJ Vaizey","year":"1999","unstructured":"Vaizey CJ, Carapeti E, Cahill JA, Kamm MA. Prospective comparison of faecal incontinence grading systems. Gut. 1999;44(1):77\u201380.","journal-title":"Gut"},{"issue":"5","key":"15643_CR15","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/SLA.0b013e31824f1c21","volume":"255","author":"KJ Emmertsen","year":"2012","unstructured":"Emmertsen KJ, Laurberg S. Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg. 2012;255(5):922\u20138.","journal-title":"Ann Surg"},{"issue":"1","key":"15643_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF02234823","volume":"44","author":"J Rothbarth","year":"2001","unstructured":"Rothbarth J, Bemelman WA, Meijerink WJ, Stiggelbout AM, Zwinderman AH, Buyze-Westerweel ME, et al. What is the impact of fecal incontinence on quality of life? Dis Colon Rectum. 2001;44(1):67\u201371.","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"15643_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ejon.2015.02.009","volume":"19","author":"XT Hou","year":"2015","unstructured":"Hou XT, Pang D, Lu Q, Yang P, Jin SL, Zhou YJ, et al. Validation of the Chinese version of the low anterior resection syndrome score for measuring bowel dysfunction after sphincter-preserving surgery among rectal cancer patients. Eur J Oncol Nursing: Official J Eur Oncol Nurs Soc. 2015;19(5):495\u2013501.","journal-title":"Eur J Oncol Nursing: Official J Eur Oncol Nurs Soc"},{"key":"15643_CR18","doi-asserted-by":"crossref","unstructured":"Chapman JD, Nahum AE. Radiotherapy treatment planning: linear-quadratic radiobiology. CRC; 2016.","DOI":"10.1201\/b18349"},{"key":"15643_CR19","doi-asserted-by":"crossref","unstructured":"Kaplan EL, Meier P. Nonparametric Estimation from incomplete observations. J Am Stat Assoc.53(282):457\u201381.","DOI":"10.1080\/01621459.1958.10501452"},{"issue":"2","key":"15643_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life-tables. J Roy Stat Soc: Ser B (Methodol). 1972;34(2):187\u2013202.","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"key":"15643_CR21","doi-asserted-by":"crossref","unstructured":"Klein JP. The statistical analysis of failure time data. Taylor & Francis; 1982.","DOI":"10.1080\/00401706.1982.10487769"},{"issue":"446","key":"15643_CR22","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496\u2013509.","journal-title":"J Am Stat Assoc"},{"issue":"9","key":"15643_CR23","first-page":"1322","volume":"37","author":"PC Austin","year":"2021","unstructured":"Austin PC, White IR, Lee DS, van Buuren S. Missing data in clinical research: A tutorial on multiple imputation. Can J Cardiol. 2021;37(9):1322\u201331.","journal-title":"Can J Cardiol"},{"key":"15643_CR24","unstructured":"Smirnov NVJBMU. Estimate of deviation between empirical distribution functions in two independent samples. 1939;2(2):3\u201316."},{"key":"15643_CR25","doi-asserted-by":"crossref","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). European journal of cancer (Oxford, England: 1990). 2009;45(2):228\u2009\u2013\u200947.","DOI":"10.1016\/j.ejca.2008.10.026"},{"issue":"6","key":"15643_CR26","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"RD James","year":"2013","unstructured":"James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 \u00d7 2 factorial trial. Lancet Oncol. 2013;14(6):516\u201324.","journal-title":"Lancet Oncol"},{"issue":"1","key":"15643_CR27","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ijrobp.2021.08.008","volume":"112","author":"LA Kachnic","year":"2022","unstructured":"Kachnic LA, Winter KA, Myerson RJ, Goodyear MD, Abitbol AA, Streeter OE, et al. Long-Term outcomes of NRG Oncology\/RTOG 0529: A phase 2 evaluation of Dose-Painted intensity modulated radiation therapy in combination with 5-Fluorouracil and Mitomycin-C for the reduction of acute morbidity in anal Canal cancer. Int J Radiat Oncol Biol Phys. 2022;112(1):146\u201357.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"15643_CR28","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.ijrobp.2007.08.074","volume":"70","author":"LK Mell","year":"2008","unstructured":"Mell LK, Schomas DA, Salama JK, Devisetty K, Aydogan B, Miller RC, et al. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70(5):1431\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"15643_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00384-023-04411-y","volume":"38","author":"M Rotondi","year":"2023","unstructured":"Rotondi M, Facondo G, Mossa S, Vullo G, Angelicone I, Valeriani M, et al. Comparative analysis of toxicity in patients with anal cancer undergoing definitive simultaneous integrated boost (SIB) or sequential integrated boost (SeqB) radiotherapy. Int J Colorectal Dis. 2023;38(1):125.","journal-title":"Int J Colorectal Dis"},{"issue":"4","key":"15643_CR30","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.ijrobp.2024.10.007","volume":"121","author":"OB Roth","year":"2025","unstructured":"Roth OB, Hristidis DA, Chakrani VC, McCann Z, Damato P, Williams A. Clinical Outcomes, patterns of Failure, and salvage therapies of a large modern cohort of patients with anal squamous cell carcinoma treated with Definitive-Intent Intensity-Modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2025;121(4):951\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"15643_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijrobp.2022.05.009","volume":"114","author":"B De","year":"2022","unstructured":"De B, Corrigan KL, Rooney MK, Ludmir EB, Das P, Smith GL, et al. Patient-Reported bowel and urinary function in Long-Term survivors of squamous cell carcinoma of the anus treated with definitive intensity modulated radiation therapy and concurrent chemotherapy. Int J Radiat Oncol Biol Phys. 2022;114(1):78\u201388.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"15643_CR32","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.ijrobp.2022.09.071","volume":"115","author":"AC Lef\u00e8vre","year":"2023","unstructured":"Lef\u00e8vre AC, Serup-Hansen E, Storm KS, Wind KL, Kronborg C, Spindler KG. One-Year Treatment-Related side effects and quality of life after chemoradiotherapy in squamous cell carcinoma of the anus. Int J Radiat Oncol Biol Phys. 2023;115(5):1165\u201377.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"15643_CR33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.radonc.2016.06.020","volume":"120","author":"K Joseph","year":"2016","unstructured":"Joseph K, Vos LJ, Warkentin H, Paulson K, Polkosnik LA, Usmani N, et al. Patient reported quality of life after helical IMRT based concurrent chemoradiation of locally advanced anal cancer. Radiotherapy Oncology: J Eur Soc Therapeutic Radiol Oncol. 2016;120(2):228\u201333.","journal-title":"Radiotherapy Oncology: J Eur Soc Therapeutic Radiol Oncol"},{"issue":"12","key":"15643_CR34","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1097\/DCR.0000000000002600","volume":"65","author":"JP Taylor","year":"2022","unstructured":"Taylor JP, Wei IH, Joshua Smith J, Tin AL, Aiken N, Vickers AJ, et al. Assessment of Patient-Reported outcomes in patients with anal Squamous-Cell cancer undergoing combined modality therapy. Dis Colon Rectum. 2022;65(12):1448\u201355.","journal-title":"Dis Colon Rectum"},{"issue":"16","key":"15643_CR35","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","volume":"30","author":"D Peiffert","year":"2012","unstructured":"Peiffert D, Tournier-Rangeard L, G\u00e9rard JP, Lemanski C, Fran\u00e7ois E, Giovannini M, et al. Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal Canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncology: Official J Am Soc Clin Oncol. 2012;30(16):1941\u20138.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"6","key":"15643_CR36","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S1470-2045(25)00213-X","volume":"26","author":"A Gilbert","year":"2025","unstructured":"Gilbert A, Adams R, Webster J, Gilbert DC, Abbott NL, Berkman L, et al. Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trial. Lancet Oncol. 2025;26(6):707\u201318.","journal-title":"Lancet Oncol"},{"issue":"4","key":"15643_CR37","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ijrobp.2013.07.035","volume":"87","author":"LL Gunderson","year":"2013","unstructured":"Gunderson LL, Moughan J, Ajani JA, Pedersen JE, Winter KA, Benson AB 3, et al. Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal intergroup RTOG 98\u2009\u2013\u200911 phase 3 trial. Int J Radiat Oncol Biol Phys. 2013;87(4):638\u201345.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"15643_CR38","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.annonc.2020.06.012","volume":"31","author":"R Glynne-Jones","year":"2020","unstructured":"Glynne-Jones R, Meadows HM, Lopes A, Muirhead R, Sebag-Montefiore D, Adams R. Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus: results of a post hoc analysis from the randomised phase III ACT II trial. Annals Oncology: Official J Eur Soc Med Oncol. 2020;31(10):1376\u201385.","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol"},{"key":"15643_CR39","doi-asserted-by":"crossref","unstructured":"Del Rivin E, Matzinger O, Haustermans K, Peiffert D, Glynne-Jones R, Winter KA et al. Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC). European journal of cancer (Oxford, England: 1990). 2019;121:130\u2009\u2013\u200943.","DOI":"10.1016\/j.ejca.2019.08.022"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15643-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15643-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15643-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:01:58Z","timestamp":1771596118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15643-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15643"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15643-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki. Ethical approval was obtained from the Ethics Committee of the Cancer Hospital, Chinese Academy of Medical Sciences (25\/415\u20135361). Informed consent was obtained from all participants in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"286"}}